On November 6, Aehr Test rose 10.23% in Regular Trading, trading at $54.0522/share, with turnover of $19.6299 million.
The move follows continued investor positioning around the company’s stronger-than-expected first-quarter results, raised full-year revenue outlook, and incremental AI chip test orders.
Recently disclosed figures showed adjusted EPS of $0.28 versus market expectations of $0.11, while revenue reached $33.007 million versus expectations of $27.072 million. The company also said backlog stood at $100.9 million as of September 25. Separately, it highlighted new AI-related demand, including added orders tied to AI chip testing and burn-in systems, reinforcing the view that AI infrastructure spending is supporting equipment demand.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)
Comments